California drug pricing transparency law hailed as success

Marjie High | Jul 11, 2018 | California

Supporters of SB 17 are hailing the drug pricing transparency law a success today after several manufactures sent required notices in the last few weeks that they are rescinding previously announced price increases. As reported by Bloomberg.com, Novartis, Gilead Sciences Inc., Roche Holding AG, and Novo Nordisk A/S sent notices to California health...[ Read More ]